Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 12/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 11/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 10/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7384105 | 1.00 | OPRM1 (0.35) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| Bromide SCHEMBL7384756 | 0.99 | OPRM1 (0.34) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| Bromide SCHEMBL7384759 | 0.99 | OPRM1 (0.34) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL7380710 | 0.90 | ALDH1A1 (0.32) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL7380713 | 0.90 | ALDH1A1 (0.32) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| Bromide SCHEMBL7384800 | 0.89 | ALDH1A1 (0.32) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| Bromide SCHEMBL7384802 | 0.89 | ALDH1A1 (0.32) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL7382048 | 0.85 | SLC6A4 (0.36) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL7382049 | 0.85 | SLC6A4 (0.36) | OPRM1SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL7382401 | 0.84 | SLC6A4 (0.35) | OPRM1SLC6A4SLC6A3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970090-B1 | SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE | KNOLL GMBH (DE) | 2002-06-05 | — | — | EP | claimed |
| US-6187802-B1 | 3-(1-(3,4-DICHLOROPHENYL)CYCLOBUTYL)-5,6-DIHYDROIMIDAZO(2,1-B) THIAZOLE, FOR EXAMPLE; ADMINISTERING TO TREAT DEPRESSION, ANXIETY, PARKINSON'S DISEASE, OBESITY, COGNITIVE DISORDERS, SEIZURES, AND FOR NEUROPROTECTION AGAINST STROKE | KNOLL AKTIENGESELLSCHAFT (DE) | 2001-02-13 | — | — | US | claimed |
| EP-0970090-A1 | SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE | Knoll AG (DE) | 2000-01-12 | — | — | EP | claimed |
| WO-1998041528-A1 | SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE | KNOLL AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | claimed |
| EP-0970090-B1 | SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE | KNOLL GMBH (DE) | 2002-06-05 | — | — | EP | disclosed |
| US-6187802-B1 | 3-(1-(3,4-DICHLOROPHENYL)CYCLOBUTYL)-5,6-DIHYDROIMIDAZO(2,1-B) THIAZOLE, FOR EXAMPLE; ADMINISTERING TO TREAT DEPRESSION, ANXIETY, PARKINSON'S DISEASE, OBESITY, COGNITIVE DISORDERS, SEIZURES, AND FOR NEUROPROTECTION AGAINST STROKE | KNOLL AKTIENGESELLSCHAFT (DE) | 2001-02-13 | — | — | US | disclosed |